The EPS projection of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for quarter ended 2016-09-30 is $1.1. A week before, the EPS forecast was $1.1 against target of $1.1, a month earlier. This estimate stood at $1.1 60 days earlier versus forecast of $1.1 90 days earlier, confirming a deviation of 0%.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) reported that 18 days ago, the positive EPS revisions were 0 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 0, 0, 0 and 0, respectively.
The downgrade of EPS estimates for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in the preceding 120, 60, 30 and 90 days were 1, 1, 0 and 1, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was $1.1. This projection was computed after accounting 3 calls. As reported on 2016-04-28 the EPS was $0.87. The change was $-0.04, demonstrating a percentage deviation of -4.4%. The projections confirmed a standard deviation of 0.09.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) stands at $836.755 and the median estimate at $829.878. Almost 8 analysts announced their estimates.
The highest estimate is $860 while the lowest target is $825.09 showing standard deviation of 13.85%.
As many as 8 analysts released sales estimates reised in upside while 8 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 8 revised sales number projection on upside while 8 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 8 hiked sales estimations and 8 reduced sales forecast. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) stated that the change in forecast was -1.705%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...